[HTML][HTML] Invasive candidiasis

PG Pappas, MS Lionakis, MC Arendrup… - Nature Reviews …, 2018 - nature.com
Invasive candidiasis is an important health-care-associated fungal infection that can be
caused by several Candida spp.; the most common species is Candida albicans, but the …

Fungal endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management

GR Thompson III, JD Jenks, JW Baddley… - Clinical microbiology …, 2023 - Am Soc Microbiol
Fungal endocarditis accounts for 1% to 3% of all infective endocarditis cases, is associated
with high morbidity and mortality (> 70%), and presents numerous challenges during clinical …

Candidemia and invasive candidiasis

TP McCarty, CM White, PG Pappas - Infectious Disease Clinics, 2021 - id.theclinics.com
Invasive infection caused by Candida species is a condition associated with medical
progress. It is a common health care–associated infection (HAI), and is widely recognized as …

Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 …

GR Thompson, A Soriano, OA Cornely, BJ Kullberg… - The Lancet, 2023 - thelancet.com
Background Rezafungin is a next-generation, once-a-week echinocandin in development
for the treatment of candidaemia and invasive candidiasis and for the prevention of invasive …

Diagnosis and treatment of invasive candidiasis

N Barantsevich, E Barantsevich - Antibiotics, 2022 - mdpi.com
Candida species, belonging to commensal microbial communities in humans, cause
opportunistic infections in individuals with impaired immunity. Pathogens encountered in …

Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America

PG Pappas, CA Kauffman, DR Andes… - Clinical infectious …, 2016 - academic.oup.com
It is important to realize that guidelines cannot always account for individual variation among
patients. They are not intended to supplant physician judgment with respect to particular …

[HTML][HTML] ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

F Tissot, S Agrawal, L Pagano, G Petrikkos… - …, 2017 - ncbi.nlm.nih.gov
Abstract The European Conference on Infections in Leukemia (ECIL) provides
recommendations for diagnostic strategies and prophylactic, pre-emptive or targeted therapy …

Invasive candidiasis

BJ Kullberg, MC Arendrup - New England Journal of Medicine, 2015 - Mass Medical Soc
Despite advances in antifungal therapy, the mortality associated with invasive candidiasis
remains as high as 40%. This review summarizes recent trends and current strategies …

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non‐neutropenic adult patients

OA Cornely, M Bassetti, T Calandra… - Clinical Microbiology …, 2012 - Wiley Online Library
Clin Microbiol Infect 2012; 18 (Suppl. 7): 19–37 Abstract This part of the EFISG guidelines
focuses on non‐neutropenic adult patients. Only a few of the numerous recommendations …

Invasive candidiasis

TP McCarty, PG Pappas - Infectious Disease Clinics, 2016 - id.theclinics.com
Invasive infection due to Candida species is a condition associated with medical progress. It
is a common health care–associated infection and is widely recognized as a major cause of …